Qiming Venture Partners VIII-HC, L.P. 13D and 13G filings for Vor Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 4:16 pm Unchanged | 2026-03-31 | 13G | VOR BIOPHARMA INC VOR | Qiming Venture Partners VIII-HC, L.P. | 1,089,767 2.000% | 0 (Unchanged) | Filing |
| 2026-02-13 7:47 pm Purchase | 2025-12-31 | 13G | VOR BIOPHARMA INC VOR | Qiming Venture Partners VIII-HC, L.P. | 1,089,767 2.800% | 593,495 (+119.59%) | Filing |
| 2025-11-05 4:14 pm Purchase | 2025-09-18 | 13G | VOR BIOPHARMA INC VOR | Qiming Venture Partners VIII-HC, L.P. | 496,272 5.440% | 496,272 (New Position) | Filing |